PLAY PODCASTS
1.	πŸ’”πŸ©Έβš–οΈ Aspirin, Anticoagulants & Harm: Rethinking Dual Therapy in Stable CAD

1. πŸ’”πŸ©Έβš–οΈ Aspirin, Anticoagulants & Harm: Rethinking Dual Therapy in Stable CAD

Dr RR Baliga's "Got Knowledge Doc" Podkast

October 27, 20254m 23s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

πŸ’ŠπŸ«€ Aspirin in the Crosshairs?

The AQUATIC Trial (NEJM, Aug 2025) raises sharp questions on dual-pathway therapy in chronic coronary syndrome (CCS) patients already on long-term anticoagulation.

πŸ“‰ Adding aspirin led to:

β€’ ↑ Ischemic events (HR 1.53; P=0.02)

β€’ ↑ Mortality (HR 1.72; P=0.01)

β€’ ↑ Major bleeding (HR 3.35; P)

🧠 Takeaway: More isn't always better. In high-risk CCS, aspirin may harm more than help.

πŸ“š Read: https://www.nejm.org/doi/full/10.1056/NEJMoa2507532

#Cardiology #Antiplatelet #NEJM #PrecisionMedicine #AQUATICTrial